Oct 19, 2020
AbbVie Announces Commencement of Registered Exchange Offers
May 07, 2020
The Allergan Foundation Doubles its COVID-19 Response Donations to $4.0 Million
May 06, 2020
Announcement relating to the outcome of the Court Sanction Hearing
May 05, 2020
AbbVie and Allergan Receive Clearance from U.S. Federal Trade Commission for AbbVie's Acquisition of Allergan
Apr 28, 2020
Announcement relating to the voluntary delisting of Allergan Notes
Apr 02, 2020
China Gives Greenlight to Allergan's XEN® Registration for the Surgical Management of Refractory Glaucoma
Mar 31, 2020
Allergan Earns ENERGY STAR® Partner of the Year - Sustained Excellence Award for the Seventh Consecutive Year
Mar 18, 2020
Allergan Declares Second Quarter 2020 Cash Dividend of $0.74 Per Ordinary Share
Mar 17, 2020
AbbVie and Allergan Sign Consent Decree Agreement with Federal Trade Commission Staff on Pending Transaction
Mar 05, 2020
Allergan Receives FDA Approval for DURYSTA(TM) (bimatoprost implant) the First and Only Intracameral Biodegradable Sustained-Release Implant to lower Intraocular Pressure in Open-Angle Glaucoma or Ocular Hypertension Patients
Mar 03, 2020
AbbVie and Allergan Receive Final European Approval to Close Pending Transaction
Feb 25, 2020
Allergan to Present New Data for Investigational Bimatoprost Sustained-Release at American Glaucoma Society Annual Meeting
Feb 14, 2020
Announcement under Rule 8.1(a) of the Irish Takeover Rules: Dealings by Offerors, Offerees or Parties Acting in Concert With Them for Themselves or for Discretionary Clients
Feb 10, 2020
Allergan Reports Fourth Quarter and Full-Year 2019 Financial Results
Jan 27, 2020
AbbVie and Allergan Announce Agreements to Divest Brazikumab and Zenpep
Jan 24, 2020
Allergan Declares First Quarter 2020 Cash Dividend of $0.74 Per Ordinary Share
Jan 17, 2020
SkinMedica® Launches New Instant Bright Eye Cream For Immediate, Visible Results
Jan 16, 2020
Allergan Teams Up With Super Bowl MVP Von Miller to Raise Awareness of Glaucoma's Impact on Daily Living
Jan 06, 2020
Warner Chilcott and Watson Resolve Antitrust Class Action Litigation with Direct and Indirect Purchasers of Loestrin 24 Fe and Minastrin 24 Fe
Dec 27, 2019
BTL Files Patent Infringement Lawsuit Against Allergan and Zimmer Related to Emsculpt